A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient. The ATOMIC2 trial, which is being led from Oxford, will enrol 800 people who are being assessed at hospital with COVID-19 but felt well enough to be cared for at home. … Read more
Drug trial could lead to enhanced respiratory care for COVID-19 patients
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals, including Oxford University Hospitals, to test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die … Read more
Study sheds light on breast cancer risk after pre-invasive disease
Women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast cancer and of death from breast cancer, compared with the general population, according to a study by Oxford researchers. DCIS is a disease where malignant breast cells are found but have … Read more
Oxford COVID-19 vaccine to begin phase II/III human trials
University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers. The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next study will enrol up to 10,260 adults and children … Read more
BRC researchers complete Next Generation Leaders Programme
Researchers supported by the NIHR Oxford Biomedical Research Centre have successfully completed the Next Generation Leaders Programme, a new initiative that was commissioned and designed by the BRC to enable early and mid-career researchers and health professionals to develop key skills in leadership as they take on more responsibility. During the six month course, participants … Read more
Social disconnection worsens mental health after a loss
Keeping grief hidden can be a survival strategy after suffering a bereavement. However new research shows that the social disconnection caused by concealing feelings of loss can increase psychological distress. After bereavement people can feel afraid of opening up about their grief to others. Fear of becoming overwhelmed by feelings in front of friends and … Read more
BRC Technology Co-theme Lead appointed as NIHR Health Technology Assessment Programme Director
Professor Andrew Farmer, the Oxford Biomedical Research Centre’s Co-theme Lead for Technology and Digital Health and an experienced general practitioner, begins a new role with the NIHR on 1 June 2020 as Health Technology Assessment (HTA) Programme Director. He will take over from Professor Hywel Williams, who will be stepping down in September after heading … Read more
BRC theme lead to study ‘remote-by-default’ care in COVID-19 pandemic
A senior Oxford BRC investigator has received major government funding for a new study to support general practitioners to deliver effective remote care to their patients during the COVID-19 pandemic. Professor Trisha Greenhalgh (pictured right), of the University of Oxford’s Nuffield Department of Primary Care Health Sciences, was awarded £750,000 from the Economic and Social … Read more
BRC Senior Research Fellows take part in masterclass on ‘leading change’
The Oxford Biomedical Research Centre’s Senior Research Fellows have taken part in a leadership masterclass led by Professor Sue Dopson, Rhodes Trust Professor of Organisational Behaviour and Deputy Dean of the Saïd Business School. The aim of the BRC’s Senior Research Fellowships is to support mid-career researchers to advance an independent research area which will … Read more
Managing clinical trials in a pandemic: interview with Prof Duncan Richards
Professor Duncan Richards, who is Director of the Oxford Clinical Trials Research Unit (OCTRU) as well as the NIHR Oxford Biomedical Research Centre’s Musculoskeletal Co-theme Lead, is at the forefront of Oxford’s strategy on clinical trials for COVID-19. In this interview with the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), he discusses how … Read more
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 51
- Next Page »